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Abstract
Background: A proportion of people who have been diagnosed with peripheral arterial disease and diabetes
mellitus will be susceptible to chronic wounds. Oxygen is vital for wound healing, so oxygen measurements should
to be taken as predictive values for wound healing in patients. When measuring oxygen at the wound bed, there is
potentially a risk of cross-infection if no protective barrier is used; and skin stripping if an adhesive barrier is used
on the wound bed. This cross sectional within subject repeated measures pilot study, aims to determine if the
application of opsite film, as an infection control measure, in one or two layers, impacts on tissue oxygenation
readings obtained when using the MoorVMS-OXY.
Methods: Mean oxygen saturation percentages were measured from 29 limbs of 18 healthy participants. Oxygen
saturation was measured for 20 s and analysed at the first metatarsophalangeal joint using no film, one and two
layers using the MoorVMS-OXY. A one-way repeated ANOVA with a Bonferroni post hoc test was performed to test
for statistically significant differences between the values of the three parameters and multiple pairwise
comparisons was completed.
Results: Amongst the three layers, there was a statistically significant difference in oxygen saturation between the
two layers of Opsite Flexigrid and none; and also between the two layers of Flexigrid and single layer (p < 0.05). It
was also established that there was no statistically significant difference between the single layer of Opsite Flexigrid
and no Flexigrid layer (p > 0.05).
Conclusions: The results imply that one layer of Opsite Flexigrid is a suitable protective barrier to use when
establishing capillary bed oxygen perfusion with the MoorVMS-OXY. However, the application of two Opsite
Flexigrid layers, to prevent skin stripping, decreases the recorded values of oxygen saturation percentages
significantly, therefore providing inaccurate results. Indicating that a double layer cannot be used over ulceration
sites if measuring oxygen levels at the wound bed.
Keywords: Oxygen saturation percentages, Opsite Flexigrid, First metatarsophalangeal joint, Skin stripping,
MoorVMS-OXY, Cross-infection
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Background
A proportion of people who are diagnosed with periph-
eral arterial disease (PAD) and diabetes mellitus may de-
velop a chronic wound [1]. A chronic wound is a break
in the skin which has failed to go through each stage of
wound healing (hemostasis, inflammation, proliferation
and maturation) in the correct time frame [2]. This can
be longer than 6 weeks or reoccurs frequently [3, 4].
Oxygen is a vital component for wound healing and a
lack of oxygen can impact every stage of the healing
process [2]. During wound healing, there is increased de-
mand for energy which is provided when oxygen is read-
ily available [5]. Energy is a fundamental requirement in
wound healing due to the increased need to aid repara-
tive processes such as, bacterial defences to prevent in-
fection, cell proliferation and synthesis of collagen [6].
Oxygen levels need to be assessed as a decrease of
oxygen in the body is associated with the development
of ischemia, PAD and a reduced healing rates [2]. There
are different methods for establishing arterial limb perfu-
sion. In routine podiatric practice, this is primarily
achieved via the use of a hand held Doppler, which
focus’ on arterial perfusion of the foot by assessing the
dorsalis pedis and the posterior tibial arteries. A study
by Ladner et al., [7] showed that transcutaneous tissue
oxygen tension measurement (TcPO2) is also a suitable
clinical screening tool for estimating the risk of foot
ulcer non-healing in patients with diabetes and absent
palpable pedal pulses. When considering the structures
assessed using this device, its focus is on arteriole and
capillary perfusion, which can provide vital information
in relation to the perfusion of the tissues in the region of
the wound. Limitations of the probes of this device are
that they heat the tissues underneath, they are larger,
more numerous and placed only around the wound mar-
gins. This does give useful information regarding the
wound periphery but does not give actual wound bed
perfusion values. The MoorVMS-OXY does provide the
means of evaluating capillary oxygen saturation at the
wound bed by utilizing white light reflectance spectros-
copy [8]. There is only one, smaller probe to apply,
which does not need to heat the tissues, therefore there
is no delay prior to taking tissue measurements. The use
of this device would enable clinicians to identify individ-
uals who may have normal artery and arteriole flow but
have capillary bed perfusion problems, which currently
are not being assessed. These two devices mentioned are
not commonly used in podiatry practice, but could pro-
vide valuable information if utilized more frequently [6,
9]. Clinicians may be concerned with applying a probe
to the wound bed itself due to infection control reasons,
concerns with cleaning the probe after use (as they are
not disposable), causing skin stripping to the peri-wound
skin on removal of a protective barrier film, if used, as
well as uncertainty as to whether the protective barrier
film used could affect the reliability of readings obtained
from the device.
Measuring oxygen saturation percentages (SO2%) at a
wound bed could place the patient at risk of infection if
performed incorrectly. All healthcare professionals are
involved with infection prevention and control and must
adhere to the quality standards to protect those who are
vulnerable [10]. To measure ulcers, infection prevention
methods must be in place. There are sterile transparent
film dressings, which allow the exchange of oxygen and
water vapour [11, 12], which could be used to allow de-
vices to measure SO2% whilst minimizing the risk of
cross-infection and allowing faster probe cleaning, post
use [13, 14]. However, these dressings adhere to the skin,
if used in a single layer, and there is the possibility that
this could leave the patient susceptible to skin stripping
on it’s removal [14–17]. Skin stripping of the peri-
wound can lead to an increase in the wound size and
additionally delay the healing process [14–17]. If these
dressings were used in a double layer, the skin stripping
element would be removed but the thickness of the
dressing may have a detrimental effect on the machine
readings.
This study aims to answer this question, does the ap-
plication of opsite film, as an infection control measure,
in one or two layers, impact on tissue oxygenation read-
ings obtained when using the MoorVMS-OXY? This
would then allow clinicians to measure the oxygen satur-
ation at the wound bed without the patient being at risk
of cross-infection or skin stripping [14–17], while main-
taining confidence in the values that are obtained.
Methods
Study design
In this quantitative within-subject repeated measure
pilot study, the same participants limb was used for the
three different experimental conditions; no Opsite Flexi-
grid, single Opsite Flexigrid and double Opsite Flexigrid.
SO2% were taken from these experimental conditions
measured on the planter surface of the 1st metatarso-
phalangeal joint (MTPJ) using the MoorVMS-OXY.
Participants
For this study 27 participants volunteered, Twenty par-
ticipants attended for the first appointment where writ-
ten consent and eligibility screening was performed. All
participants met the inclusion criteria, however, only
eighteen participants returned for the data collection ap-
pointment. The participants did not have any history of
anemia, PAD, previous myocardial infarction, heart at-
tack, sickle cell disease, leukemia, carbon monoxide poi-
soning, and monophasic pulses. All Participants had a
Fitzpatrick score of 1 or 2, alongside biphasic or
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triphasic pulses (using a Doppler Ultrasound) and good
skin integrity. The Fitzpatrick skin classification system
is a tool which can be used to classify the amount of
melanin pigment in the skin along with how the skin re-
acts following exposure to sunlight. The MoorVMS
OXY has been validated for Fitzpatrick skin types 1 and
2, and is reported to not be as effective in the other skin
classification types due to the melanin reflecting the
white light of the device [18]. In addition, the following
were excluded: under 18 years old, being a present
smoker, pregnant, a high alcohol intake (over 14 units a
week), an allergy to Opsite Flexigrid, latex or Mefix tape
and a skin type of 3 to 6 on the Fitzpatrick Scale [18].
Of the original twenty consented participants, eighteen
participants returned for the second step of the project.
Of these eighteen recruited (36 limbs), the data collected
from 7 limbs was used to optimize the data collection
method and ensure efficient use of the MoorVMS-OXY
and thus was excluded from the final data set, leaving
the data from 29 participant limbs being used for the
data analysis. The mean Participant age was 27.6 years
old (range: 20–48).
All participants signed a written consent in accordance
with the ethics committee on human subjects as re-
quired by the university before participation. The study
protocol was approved by the School Research Ethics
and Governance Panel, University of Brighton on the
21st June 2017.
Instrumentation and equipment protocol
MoorVMS-OXY (moorinstruments) is a white-light re-
flectance spectroscopy device, using wave lengths ran-
ging from 500 nm–650 nm [8, 19]. For an overall tissue
SO2%, back-scattered light reflects the concentration of
haemoglobin in the red blood cells [8, 19]. This mea-
sures the haemoglobin SO2% in the capillaries and veins
of microcirculation in the tissue, providing evidence of
changes in the microvascular blood supply and tissue
oxygen consumption [8, 9, 19].
The probe (PH1-V2) used measures to a tissue depth
of 1-2 mm of the upper tissue [8]. SO2% were recorded
on the 1st MTPJ of each participant using the
MoorVMS-OXY and MoorVMS-PC program to collect
anonymized participant data. The measurements, at this
site, were performed in triplicate for each participant
with the following conditions, no Opsite Flexigrid,
Opsite Flexigrid and double Opsite Flexigrid. The probe
cleansing, application and collection protocol was ob-
tained following guidance from the user manual [19].
For the probe to be attached onto the 1st MTPJ, the
probe was attached to the probe holder and moorPAD
adhesive discs were attached to the probe to adhere onto
the 1st MTPJ. A calibration check was made before each
measurement by following the manufacturer’s guidelines.
The detected signal was processed and displayed as ‘cali-
bration successful’. The measureable range of SO2 is 0–
99%, however a ‘normal’ value of SO2 in the leg or arm
ranges from 20 to 50%, and the lesser digits 50–80% [8].
Data was collected continuously over a 30 s period for
each test condition, whereby a 20 s region of interest for
each layer was selected for analysis (5 s off the start and
end of each 30 s period). The MoorVMS-OXY performs
a reading every 0.025 s, therefore, during the 20 s data
collection period, 800 individual data capture points
were collected. This data was used to calculate the
means, standard deviations (SD) and SD errors were cal-
culated for the three test environments on each partici-
pant. All data collected is expressed as mean ± SD.
Opsite Flexigrid is a sterile, transparent, semi-
permeable film wound dressing made of a polyurethane
membrane with an acrylic adhesive layer (Smith &
Nephew UK, Cutifilm) [20]. As it is semipermeable, it
means it is permeable to water vapour and oxygen, how-
ever it is impermeable to micro-organisms [20, 21]. A
single Opsite Flexigrid was used because Opsite Flexigrid
is an effective barrier to external contamination, redu-
cing the risks of cross-infection. It allows excess exudate
to evaporate while providing a moist environment at the
surface of the wound to ensure an optimum wound
healing environment [20, 21]. However, there is an
acrylic adhesive layer, which is reasonable for patients
who have no skin integrity issues and are not at risk to
infection [20, 21].], using this on a patient with an ulcer
could lead to skin stripping [17]. Opsite Flexigrid has a
tendency for skin stripping to occur on a new epidermis
from recently re-epithelized areas of the wound [11, 22].
So, to prevent skin stripping occurring a double Opsite
Flexigrid was made by folding one Opsite Flexigrid into
two (adhesive sides adhered together) where Mefix held
the double Opsite Flexigrid in place. For the single
Opsite Flexigrid, the dressing (size 6 × 7 centimetres)
was cut in half.
To ensure accuracy of the data collected, each re-
searcher did the same task throughout the project.
The data collection ran for a period of 4 weeks.
There were two appointments given, the first appoint-
ment was to collect participant information for inclu-
sion, exclusion criteria, and gaining informed, written
consent. All data collected was coded for participant
anonymity.
If the participant passed the inclusion, exclusion cri-
teria, a second appointment was booked. However, at
least 24 h was given before that appointment to allow
participants to opt out if they wanted to. On the second
appointment, the data was collected on both limbs of
each participant.
For data collecting, firstly, the participants had to
acclimatise in the treatment room, the observed room
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temperature was observed to be 21-24 °C for 15 min
[23] in a resting upright sitting position, with feet
elevated.
Prior to data collection, the foot was wiped using a
standard clinical procedure (patient Carell wipes) be-
fore setting up the device and following Moor VMS
protocol. The probe was cleaned before and after use
following manufacturer recommendations [19]. To en-
sure accuracy of the data collected, a sterile surgical
marker was used, where an area on the 1st MTPJ was
outlined, to enable the same position to be measured
for each layer. The 1st MTPJ was measured as previ-
ous research has suggested that it is the most com-
mon weight-bearing ulceration site [24, 25].
The MoorVMS-OXY was switched on, calibrated
and then the probe was attached onto the outlined
area. For no layer of Opsite Flexigrid, the data was
collected for 30 s, then the device was paused. Whilst
it was paused, the probe was removed, then a sterile
single Opsite Flexigrid was applied over the same
area, recorded data for another 30 s, then paused
again. The process was again repeated for the sterile
double Opsite Flexigrid (making sure there were no
air bubbles) held using Mefix.
The data was collected using the moorVMS-PC pro-
gram alongside the MoorVMS-OXY, then transferred
onto Excel to plot the data.
Statistical analysis
Statistical analysis was conducted using IBM SPSS
Statistics Desktop, version 24.0, Mac OS. All data was
tested for normality using the Shapiro-Wilk test. Means
and SD was calculated for each variable. A one-way re-
peated Analysis of Variance (ANOVA) was used to test
for significant differences in SO2% across the within-
subjects factor (no Opsite Flexigrid, single Opsite Flexi-
grid, double Opsite Flexigrid). A Bonferroni post hoc
test was used for multiple pairwise comparisons between
the three variables whilst also providing the statistical
significance level for each pairwise comparison. The
level of significance was set at p < 0.05.
Results
The eighteen participants included undertook the proto-
col without complications and no participants withdrew
from the study. The data was obtained from 29 of the
available 36 participant limbs. For the purposes of calcu-
lating the results n = the number of participant limbs in-
cluded in the study will be used, thus n = 29. The data
was normally distributed, as assessed by box plotting,
see Fig. 1, and performing a Shapiro-Wilk test on the re-
sults, p-value is greater than 0.05 (no Opsite Flexigrid:
p = 0.267, single Opsite Flexigrid: p = 0.331, double
Opsite Flexigrid: p = 0.148) respectively. Mauchly’s test
of sphericity showed that the assumption of sphericity
had not been violated.
Descriptive Statistics showed that the highest measure
of SO2% occurred at the 1st MTPJ with no Opsite Flexi-
grid (mean: 49.1241, SD: 11.59990), followed by a slight
SO2% decrease with a single layer of Opsite Flexigrid
(mean: 48.7241, SD: 12.77298). However, an even further
SO2% decrease with a double Opsite Flexigrid at the 1st
MTPJ (mean: 45.2069, SD: 12.46208).
Figure 1 shows the mean SO2% of each participant
from the samples across the independent variables. This
shows that as the OF layers increase the SO2% decrease.
The SO2% ranges from layer to layer; no Opsite Flexigrid
ranges from 24.0–67.8%, single Opsite Flexigrid ranges
from 23.6–72.0% and double Opsite Flexigrid ranges
from 13.2–64.9%.
After performing the one way repeated ANOVA, it
was shown that SO2% was statistically significant at the
different layers; F (2,56) = 4.501, p < 0.05, p = 0.015. Pair-
wise comparisons further showed the mean differences
in SO2% between each of the layers and whether it is
statistically significantly different or not. See Table 1. A
single layer of Opsite Flexigrid compared to no Opsite
Flexigrid has a decreased mean difference of 0.400,
however was not statistically significant different because
p > 0.05, p = 1.000 (95% confidence interval, − 4.584 to
3.784). The mean differences for a double layer of Opsite
Flexigrid versus no Opsite Flexigrid decreased by 3.917,
and double layer of Opsite Flexigrid versus a single layer
of Opsite Flexigrid decreased by 3.517. This shows that
mean values for double Opsite Flexigrid versus no
Opsite Flexigrid (p = 0.037, 95% confidence interval, −
7.640 to − 0.195), and double Opsite Flexigrid versus
single Opsite Flexigrid (p = 0.016, 95% confidence inter-
val, − 6.484 to − 0.551) have a statistically significant
difference (p < 0.05).
Estimated marginal means of oxygen saturation
There is a general negative correlation of mean SO2%, il-
lustrated in Fig. 2. There is a high estimated SO2% mar-
ginal mean for no Opsite Flexigrid, with a gradual
decrease for a single layer of Opsite Flexigrid, then a
rapid decrease for a double layer of Opsite Flexigrid.
Therefore, the evidence shows that Opsite Flexigrid
does affect SO2% compared to when no Opsite Flexigrid
is used. The findings specifically suggest that a double
Opsite Flexigrid greatly affects SO2%, more so than a
single layer.
Discussion
The purpose of this study was to investigate whether ap-
plying a sterile transparent film wound dressing would oc-
clude the SO2% value collected by the MoorVMS-OXY
and it has been proved that it does, but not significantly.
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However, the application of a double layer of Opsite
Flexigrid does significantly alter the results obtained. It
also endeavored to consider how this may assist in its
clinical application when considering preventing cross in-
fection and / or skin stripping, on the most common
weight-bearing ulceration site of the foot [24, 25].
The MoorVMS-OXY has been used in a range of stud-
ies proving it is a functional and reliable device to use. It
has been used on the following; Wistar rats [26],
Sprague-Dawley rats [27], mice [28], pigs [29], and
humans; on the forearm [30] and forehead [31]. It is not
limited to measuring specific body parts and has the po-
tential to be utilized in clinical practice more frequently
than it is at present. This device has been validated as
reliable and accurate in measuring SO2% in a skin phan-
tom and human skin [32]. Alongside this, results have
shown that measuring oxygen and tissue perfusion can
be an early indicator of compromised tissue function
Table 1 Pairwise Comparisons
Pairwise Comparisons Measure: SO2
Layers Layers Mean
Difference
Sig.
b
95% Confidence Interval for Difference b
Lower Bound Upper Bound
0 Layers 1 Layer .400 1.000 −3.784 4.584
2 Layers 3.917a .037 .195 7.640
1 Layer 0 Layers −.400 1.000 −4.584 3.784
2 Layers 3.517a .016 .551 6.484
2 Layers 0 Layers −3.917a .037 −7.640 −.195
1 Layer −3.517a 0.16 −6.484 −.551
Based on estimated marginal means
a The mean difference is significant at the 0.05 level
b Adjustment for multiple comparisons: Bonferroni
Fig. 1 Oxygen saturation percentages compared to layers of Opsite Flexigrid
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[30]. Otherwise, there is limited literature on the use of
the Moor VMS-OXY and wound healing, with the ma-
jority of the previous research focusing on comparing
oxygen measurement using this device and others, such
as, Near infra-red Spectroscopy (NIRS), pulse oximetry
and TcPO2. The human studies identified were to; pre-
dict results for wound healing with Hyperbaric Oxygen
Therapy [33], detect stages of chronic arterial insuffi-
ciency of lower extremities [34], and to determine lower
limb oxygenation values [35]. These studies each have
different limitations, ranging from the participants,
measurement sites and comparison devices used. For ex-
ample, to measure capillary oxygenation using TcPO2,
the transducer needs to heat to 42 °C, which is not suit-
able for long-term monitoring and is invasive [33]. NIRS
cannot measure oxygen values through adipose tissue,
thus limiting its use, [35] and pulse oximetry can only
measure capillary SO2% on the peripheries; limiting its
clinical use [34].
Of these studies, only one [33] mentions using
methods to prevent cross-infection occurring which
were; sterilizing or sanitizing the device, the participants
skin, or using a sterile barrier.
This study illustrated that a double layer of Opsite
Flexigrid decreases SO2% values and this is likely due to
the thickness of Opsite Flexigrid itself and the probe be-
ing able to only measure up to a depth of 1-2 mm [8].
When considering the use of a sterile barrier to pro-
tect the wound bed, there are many sterile transparent
film dressings on the market other than Opsite Flexigrid.
Each of these film dressings may have different thick-
nesses, therefore, the authors recommend trying to iden-
tify the thinnest film dressing on the market to establish
if this affects the oxygen saturation values obtained.
Currently the results indicate that a double layer of
Opsite Flexigrid cannot be used when measuring SO2%
in wounds because it occludes the probe and affects the
values obtained. Using a single layer of Opsite Flexigrid
marginally decreases the SO2% value compare to no
Opsite Flexigrid, however this was shown to have no
statistical significant difference, suggesting a single layer
of Opsite Flexigrid could be used in clinical practice. It
would be beneficial if the study were repeated with a lar-
ger sample size to consolidate the findings and provide
results more representative to the larger population.
It is acknowledged that skin stripping could occur
using a single Opsite Flexigrid, if placed directly on the
skin, when measuring SO2% in wounds. Therefore, a fu-
ture study using a single Opsite Flexigrid with the adhe-
sive side stuck to the probe, compared to the single
Opsite Flexigrid being stuck on the patient would pro-
vide evidence on whether there is a difference in read-
ings or not. This would in turn prevent skin stripping
and/or cross infection occuring in patients.
Fig. 2 Estimated Marginal Means of Oxygen Saturation
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There are limitations concerning the design of this
study. Firstly, the relatively small sample size (n = 29)
alongside the participant gender ratio (5 male: 24 fe-
male). A larger sample size generated by a power calcu-
lation would enable greater power to detect and
extrapolate significant differences (such as gender and
ethical diversities), ensuring the study to be more robust.
Within the larger sample size, an equal gender ratio
would be beneficial because the results would be more
representative of the population. We also acknowledge
that with within subjects study design there is a potential
for carry over effects to be observed. Therefore we rec-
ommend readers consider these potential limitations. To
potentially help to address these issues, it would be
worth randomizing the order of the 3 measurement sets,
should the project be repeated to expand the data set.
Strong skin pigmentation can cause compromised re-
sults [19]. Using the Fitzpatrick Scale [18] allowed elim-
ination of the participants which had a higher skin score.
However, limiting the study participants to skin types 1
and 2. This does not allow a true clinical representation
of SO2% amongst the entire population and its use in
participants with a higher Fitzpatrick Skin score should
be avoided. However, if measuring SO2% at a wound
bed, there is no Melanin present at that point, therefore,
further research is required into whether this device can
be used in higher Fitzpatrick skin scores if measuring
the base of open ulcerations. This would expand its use
further in clinic and make it a more versatile machine.
A limitation of the study was that participants were in a
rested seated position, rather than laying supine or prone.
Being supine or prone may have given more accurate re-
sults because it allows the effects of gravity to be elimi-
nated at the foot / probe interface [36, 37]. Previous
studies implemented this in their methods so it was not
considered a confounding variable [30, 31, 33–35, 37].
Conclusions
To conclude, there are very few MoorVMS-OXY studies
done on humans, but from the literature found, it is
used widely showing it is reliable and clinically applic-
able [26–32]. Oxygen is vital to ensure wound healing,
and a lack of oxygen can delay the healing process [2].
Monitoring SO2% in patients with ulcers, whom may
have PAD and diabetes mellitus, [1] is very important
because SO2% can be used as a predictor for healing
times [2, 6, 9], consequently allowing health profes-
sionals to form management plans for each patient.
Continuous monitoring of SO2% provides tracking of
progression and/or regression of wound healing.
From this study’s findings, the application of double
Opsite Flexigrid significantly decreases the SO2% values
obtained compared to when no Opsite Flexigrid is ap-
plied, therefore occluding readings generated by the
MoorVMS-OXY. This suggests that double Opsite Flexi-
grid cannot be used when measuring SO2%. However, a
single Opsite Flexigrid marginally decreases the SO2%,
but still partially occludes the readings. It is recom-
mended that a single layer could be used, when obtain-
ing measurements from the wound bed, in order to
allow easier cleaning of the probe and to minimise cross
infection risk. The single layer of Opsite Flexigrid can be
applied directly to the probe or to the skin, however the
clinician needs to be aware of potential skin stripping, if
used on the skin. The results obtained with a single
Opsite Flexigrid layer will impact on the results mi-
nutely, but not significantly, so should provide some re-
assurance that the values are as close to those obtained
with no Opsite Flexigrid, but while providing greater in-
fection control measures.
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